Overslaan en naar de inhoud gaan

The Company held a presentation for analysts at 13:30CET/07:30ET on 28 October 2021.  To watch the recording of the call please follow the link below: 

https://webcast.openbriefing.com/pharming-q321/

The call slides are available for download below. 

 

"I look forward to the read-out of the registration enabling study for leniolisib, expected early in the new year, as a product with transformational potential for APDS patient’s lives and also transformational commercial potential for Pharming"

- Sijmen de Vries - CEO
Cookies: Deze website maakt gebruik van cookies. Bekijk de cookie instellingen pagina voor meer informatie Accepteren Weigeren